首页 > 最新文献

Annales de biologie clinique最新文献

英文 中文
[Hematological analyzer Sysmex XN-1000: Contribution of the "iRBC?" flag in the diagnostic guidance of malaria in endemic areas]. [血液分析仪 Sysmex XN-1000:"iRBC? "标志对疟疾流行地区疟疾诊断指导的贡献]。
Pub Date : 2025-02-17 DOI: 10.1684/abc.2025.1940
Oumar Sourabié, Stéphane Sidbewendin Nana, Wenceslas N'faa Soma, Djima Fahriane Dora Koulybari, Jérôme Debus, Salam Sawadogo, Koumpingnin Nébié, Eléonore Kafando

The Sysmex XN-1000 cellular hematology analyzers, widely used in Burkina Faso, can provide information on Plasmodium infection with the "iRBC?" flag triggered during a blood count. This study aims to evaluate the contribution of this alarm to the diagnostic orientation of malaria in an endemic area. The samples were collected between August and September 2023. The blood was sampled on EDTA tubes and the blood count was performed on the Sysmex XN-1000. The Sysmex XN-31 was used as a reference diagnostic method for malaria and identification of the Plasmodium falciparum species. Identification of the non-falciparum species and non-plasmodial inclusions was made on blood smears stained with the RAL MCDh kit. 148 samples were analyzed. Children under 5 years of age represent 63.5%, and females 52.7%. The "iRBC?" flag shows a PPV and an overall specificity to malaria of 100%. Depending on the species, the sensitivity was 12.3% (13/106) for P. falciparum and 83.3% (5/6) for P. malariae. Non-plasmodial inclusions were not associated with triggering this flag. This alarm triggered by the XN series automatons can help to anticipate the diagnosis of malaria. Particular attention from the biologist is necessary during biological validation: the presence of this alarm should lead to specific malaria research, but its absence should not lead to exclude malaria, especially with P. falciparum.

在布基纳法索广泛使用的Sysmex XN-1000细胞血液学分析仪可以通过在血细胞计数期间触发的“iRBC?”标志提供关于疟原虫感染的信息。本研究旨在评估该警报对疟疾流行地区的诊断方向的贡献。这些样本是在2023年8月至9月期间收集的。在EDTA管上采集血液,在Sysmex XN-1000上进行血液计数。采用Sysmex XN-31作为疟疾和恶性疟原虫鉴定的参考诊断方法。用RAL MCDh试剂盒对血涂片进行非恶性种和非疟原虫包涵体的鉴定。共分析148份样品。5岁以下儿童占63.5%,女性占52.7%。“iRBC?”标志显示PPV和对疟疾的总体特异性为100%。对恶性疟原虫和疟疾疟原虫的敏感性分别为12.3%(13/106)和83.3%(5/6)。非质体内含物与触发该标志无关。这种由XN系列自动装置触发的警报有助于预测疟疾的诊断。生物学家在生物学验证过程中必须给予特别关注:这种警报的存在应导致专门的疟疾研究,但不应导致排除疟疾,特别是恶性疟原虫。
{"title":"[Hematological analyzer Sysmex XN-1000: Contribution of the \"iRBC?\" flag in the diagnostic guidance of malaria in endemic areas].","authors":"Oumar Sourabié, Stéphane Sidbewendin Nana, Wenceslas N'faa Soma, Djima Fahriane Dora Koulybari, Jérôme Debus, Salam Sawadogo, Koumpingnin Nébié, Eléonore Kafando","doi":"10.1684/abc.2025.1940","DOIUrl":"10.1684/abc.2025.1940","url":null,"abstract":"<p><p>The Sysmex XN-1000 cellular hematology analyzers, widely used in Burkina Faso, can provide information on Plasmodium infection with the \"iRBC?\" flag triggered during a blood count. This study aims to evaluate the contribution of this alarm to the diagnostic orientation of malaria in an endemic area. The samples were collected between August and September 2023. The blood was sampled on EDTA tubes and the blood count was performed on the Sysmex XN-1000. The Sysmex XN-31 was used as a reference diagnostic method for malaria and identification of the Plasmodium falciparum species. Identification of the non-falciparum species and non-plasmodial inclusions was made on blood smears stained with the RAL MCDh kit. 148 samples were analyzed. Children under 5 years of age represent 63.5%, and females 52.7%. The \"iRBC?\" flag shows a PPV and an overall specificity to malaria of 100%. Depending on the species, the sensitivity was 12.3% (13/106) for P. falciparum and 83.3% (5/6) for P. malariae. Non-plasmodial inclusions were not associated with triggering this flag. This alarm triggered by the XN series automatons can help to anticipate the diagnosis of malaria. Particular attention from the biologist is necessary during biological validation: the presence of this alarm should lead to specific malaria research, but its absence should not lead to exclude malaria, especially with P. falciparum.</p>","PeriodicalId":93870,"journal":{"name":"Annales de biologie clinique","volume":"83 1","pages":"73-82"},"PeriodicalIF":0.0,"publicationDate":"2025-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143443011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The pearls of myeloma: Russell bodies and Mott cells. 骨髓瘤的珍珠:罗素体和莫特细胞。
Pub Date : 2025-02-04 DOI: 10.1684/abc.2024.1936
Radu Chiriac, Zofia Gross
{"title":"The pearls of myeloma: Russell bodies and Mott cells.","authors":"Radu Chiriac, Zofia Gross","doi":"10.1684/abc.2024.1936","DOIUrl":"10.1684/abc.2024.1936","url":null,"abstract":"","PeriodicalId":93870,"journal":{"name":"Annales de biologie clinique","volume":"82 6","pages":"663-664"},"PeriodicalIF":0.0,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143082550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complementarity between Bayesian Internal Quality Control results management and External Quality Assessment bivariate z-score analysis: application to a concrete case study. 贝叶斯内部质量控制结果管理与外部质量评估二元z分数分析的互补性:在具体案例研究中的应用。
Pub Date : 2025-02-04 DOI: 10.1684/abc.2024.1934
Emilie Jousselme, Piet Meijer, Frédéric Sobas, Panagiotis Tsiamyrtzis

It is important that a clinical laboratory has implemented appropriate procedures for quality control, which includes both internal quality control (IQC) and external quality assessment (EQA) with the common goal to detect systematic errors and random errors. It is the case for both the Hemohub® Bayesian tools for IQC results interpretation and the ECAT EQA optimised bivariate z-scores analysis. On a concrete case study, we demonstrate both the higher sensitivity and specificity of optimised bivariate z-scores analysis than the univariate approach. The Bayesian IQC results interpretation like the ECAT analysis confirmed the explicit conclusion i.e. an increase of the random error corresponding to the increase of the inter assay coefficient of variation (CV) at the date of EQA samples runs. Improvement of repaired dysfunction could be then daily observed on IQC results and then confirmed on EQA results thanks to the complementarity of the two approaches.

重要的是,临床实验室实施了适当的质量控制程序,其中包括内部质量控制(IQC)和外部质量评估(EQA),其共同目标是检测系统错误和随机错误。用于IQC结果解释的haemhub®贝叶斯工具和ECAT EQA优化的双变量z分数分析都是如此。在一个具体的案例研究中,我们证明了优化的双变量z分数分析比单变量方法具有更高的灵敏度和特异性。与ECAT分析一样,贝叶斯IQC结果解释证实了明确的结论,即在EQA样品运行日期,随机误差的增加对应于测定间变异系数(CV)的增加。由于两种方法的互补性,可以在IQC结果上每天观察修复功能障碍的改善,然后在EQA结果上确认。
{"title":"Complementarity between Bayesian Internal Quality Control results management and External Quality Assessment bivariate z-score analysis: application to a concrete case study.","authors":"Emilie Jousselme, Piet Meijer, Frédéric Sobas, Panagiotis Tsiamyrtzis","doi":"10.1684/abc.2024.1934","DOIUrl":"10.1684/abc.2024.1934","url":null,"abstract":"<p><p>It is important that a clinical laboratory has implemented appropriate procedures for quality control, which includes both internal quality control (IQC) and external quality assessment (EQA) with the common goal to detect systematic errors and random errors. It is the case for both the Hemohub® Bayesian tools for IQC results interpretation and the ECAT EQA optimised bivariate z-scores analysis. On a concrete case study, we demonstrate both the higher sensitivity and specificity of optimised bivariate z-scores analysis than the univariate approach. The Bayesian IQC results interpretation like the ECAT analysis confirmed the explicit conclusion i.e. an increase of the random error corresponding to the increase of the inter assay coefficient of variation (CV) at the date of EQA samples runs. Improvement of repaired dysfunction could be then daily observed on IQC results and then confirmed on EQA results thanks to the complementarity of the two approaches.</p>","PeriodicalId":93870,"journal":{"name":"Annales de biologie clinique","volume":"82 6","pages":"645-650"},"PeriodicalIF":0.0,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142848591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Treatment of Dravet disease and false urine testing with ecstasy: a little-known interference]. [用摇头丸治疗德拉韦病和假尿检:一种鲜为人知的干扰]。
Pub Date : 2025-02-04 DOI: 10.1684/abc.2024.1931
Romain Magny, Mathieu Le Seigle, Chrystelle Oppon, Pauline Thiebot, Laurence Labat, Pascal Houzé

Urine drug screening is carried out on numerous automated analysis platforms using enzyme-linked immunosorbent assays. While these methods are rapid, they often lack specificity. We report the case of a 5-year-old child treated for Dravet disease and hospitalized for clonic seizures. During her hospitalization, 3 urine samples were sent to the Toxicology laboratory to rule out any toxic origin to these seizures. The first two were positive for ecstasy, and negative for other drugs. For the last sample, all tests were negative. The presence of ecstasy in the first 2 samples was not confirmed by gas chromatography-mass spectrometry, which identified stiripentol in all 3 urines. Stiripentol is an antiepileptic drug that shares a 3,4-methylenedioxy group with MDMA. We determined that the antibody in the kit crossed 20% with stiripentol, and were able to define a stiripentol cut-off concentration of 2,500 ng/mL. We checked this cut-off by measuring stiripentol in the 3 urine samples, finding concentrations of 47,600 and 5,800 ng/mL for the first and second samples respectively, and 1,900 ng/mL for the last. These concentrations explain the false positives in the first two urine samples, and the negative result in the last. This work underlines the need to remain critical of the results of immuno-screening methods, and to confirm them with a reference method.

尿液药物筛选是在许多自动化分析平台上使用酶联免疫吸附法进行的。虽然这些方法快速,但它们往往缺乏特异性。我们报告的情况下,5岁儿童治疗德拉韦病和住院的慢性癫痫发作。在她住院期间,三份尿液样本被送到毒理学实验室,以排除癫痫发作的任何毒性来源。前两名摇头丸呈阳性,其他药物呈阴性。对于最后一个样本,所有测试都是阴性的。气相色谱-质谱联用法未证实前两份尿样中存在摇头丸,但在所有3份尿样中均发现了斯瑞戊醇。stiripentool是一种抗癫痫药物,与MDMA共用一个3,4-亚甲基二氧基。我们确定试剂盒中的抗体与斯瑞戊醇交叉20%,并且能够确定斯瑞戊醇的截止浓度为2,500 ng/mL。我们通过测量3个尿样中的斯瑞戊醇来检查这个截止值,第一个和第二个尿样的浓度分别为47600和5800 ng/mL,最后一个尿样的浓度为1900 ng/mL。这些浓度解释了前两个尿样的假阳性和最后一个尿样的阴性结果。这项工作强调需要对免疫筛查方法的结果保持批评,并用参考方法确认它们。
{"title":"[Treatment of Dravet disease and false urine testing with ecstasy: a little-known interference].","authors":"Romain Magny, Mathieu Le Seigle, Chrystelle Oppon, Pauline Thiebot, Laurence Labat, Pascal Houzé","doi":"10.1684/abc.2024.1931","DOIUrl":"10.1684/abc.2024.1931","url":null,"abstract":"<p><p>Urine drug screening is carried out on numerous automated analysis platforms using enzyme-linked immunosorbent assays. While these methods are rapid, they often lack specificity. We report the case of a 5-year-old child treated for Dravet disease and hospitalized for clonic seizures. During her hospitalization, 3 urine samples were sent to the Toxicology laboratory to rule out any toxic origin to these seizures. The first two were positive for ecstasy, and negative for other drugs. For the last sample, all tests were negative. The presence of ecstasy in the first 2 samples was not confirmed by gas chromatography-mass spectrometry, which identified stiripentol in all 3 urines. Stiripentol is an antiepileptic drug that shares a 3,4-methylenedioxy group with MDMA. We determined that the antibody in the kit crossed 20% with stiripentol, and were able to define a stiripentol cut-off concentration of 2,500 ng/mL. We checked this cut-off by measuring stiripentol in the 3 urine samples, finding concentrations of 47,600 and 5,800 ng/mL for the first and second samples respectively, and 1,900 ng/mL for the last. These concentrations explain the false positives in the first two urine samples, and the negative result in the last. This work underlines the need to remain critical of the results of immuno-screening methods, and to confirm them with a reference method.</p>","PeriodicalId":93870,"journal":{"name":"Annales de biologie clinique","volume":"82 6","pages":"668-672"},"PeriodicalIF":0.0,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142923979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Plasma from heparinate lithium tube with separator gel allows measurement of a large panel of automated biochemical and hormonal parameters]. [血浆从肝磷脂锂管分离凝胶允许测量一个大面板的自动化生化和激素参数]。
Pub Date : 2025-02-04 DOI: 10.1684/abc.2024.1938
Elodie Georges, Didier Chevenne, Leila Drira, Nicolas de Roux, Ludmia Taibi

The preservation of blood capital is essential in many clinical situations. The laboratory, by optimizing the tubes to be sampled, provides valuable assistance in this context. The aim of this work is to study the possibility of analyzing an expanded panel of usual biochemistry and automated hormonal parameters on a single tube: heparin lithium with separator gel. Thirty-two blood samples were analyzed for a usual biochemistry panel (ALT, uric acid, albumin, AST, bicarbonates, total bilirubin, calcium, chloride, creatine kinase, creatinine, iron, GGT, glucose, haptoglobin, LDH, magnesium, PAL, inorganic phosphorus, potassium, total protein, sodium, triglycerides, urea) and a hormonal automated panel (cortisol, hGH, insulin, prolactin, free T3, free T4, TSH, B12 vitamin). For each panel, the sample was taken from the laboratory's classically recommended tube (lithium heparin without separator gel for usual biochemistry and plain without separator gel for automated hormonology) and from the single tube to be tested (heparin lithium with separator gel). The results of the recommended tubes were compared to those of the single tube, statistically and then with regard to the clinical impact. Significant differences were observed between the recommended tube and the single tube for: AST, calcium, chloride, GGT, LDH and phosphorus. Apart from LDH, no parameter revealed a clinically significant difference. Plasma collected on lithium heparin with separator gel is suitable for the determination of a wide range of biochemistry parameters, except for LDH, which should need an adaptation of its usual values with regard to the considered tube.

在许多临床情况下,血液资本的保存是必不可少的。实验室通过优化要取样的试管,在这方面提供了宝贵的帮助。这项工作的目的是研究在单管上分析常规生物化学和自动激素参数的扩展面板的可能性:肝素锂与分离凝胶。对32份血样进行常规生化检查(ALT、尿酸、白蛋白、AST、碳酸氢盐、总胆红素、钙、氯化物、肌酸激酶、肌酐、铁、GGT、葡萄糖、触球蛋白、LDH、镁、PAL、无机磷、钾、总蛋白、钠、甘油三酯、尿素)和激素自动检查(皮质醇、生长激素、胰岛素、催乳素、游离T3、游离T4、TSH、维生素B12)。对于每个面板,样品取自实验室经典推荐的试管(用于常规生化的不带分离凝胶的锂肝素,用于自动激素的不带分离凝胶的普通肝素)和待测的单管(带分离凝胶的锂肝素)。将推荐管的结果与单管的结果进行统计比较,然后考虑临床影响。推荐管与单管的AST、钙、氯、GGT、LDH、磷含量差异有统计学意义。除LDH外,其他参数均无显著差异。用分离凝胶在肝素锂上收集的血浆适用于多种生物化学参数的测定,但LDH除外,LDH需要根据所考虑的试管调整其通常值。
{"title":"[Plasma from heparinate lithium tube with separator gel allows measurement of a large panel of automated biochemical and hormonal parameters].","authors":"Elodie Georges, Didier Chevenne, Leila Drira, Nicolas de Roux, Ludmia Taibi","doi":"10.1684/abc.2024.1938","DOIUrl":"10.1684/abc.2024.1938","url":null,"abstract":"<p><p>The preservation of blood capital is essential in many clinical situations. The laboratory, by optimizing the tubes to be sampled, provides valuable assistance in this context. The aim of this work is to study the possibility of analyzing an expanded panel of usual biochemistry and automated hormonal parameters on a single tube: heparin lithium with separator gel. Thirty-two blood samples were analyzed for a usual biochemistry panel (ALT, uric acid, albumin, AST, bicarbonates, total bilirubin, calcium, chloride, creatine kinase, creatinine, iron, GGT, glucose, haptoglobin, LDH, magnesium, PAL, inorganic phosphorus, potassium, total protein, sodium, triglycerides, urea) and a hormonal automated panel (cortisol, hGH, insulin, prolactin, free T3, free T4, TSH, B12 vitamin). For each panel, the sample was taken from the laboratory's classically recommended tube (lithium heparin without separator gel for usual biochemistry and plain without separator gel for automated hormonology) and from the single tube to be tested (heparin lithium with separator gel). The results of the recommended tubes were compared to those of the single tube, statistically and then with regard to the clinical impact. Significant differences were observed between the recommended tube and the single tube for: AST, calcium, chloride, GGT, LDH and phosphorus. Apart from LDH, no parameter revealed a clinically significant difference. Plasma collected on lithium heparin with separator gel is suitable for the determination of a wide range of biochemistry parameters, except for LDH, which should need an adaptation of its usual values with regard to the considered tube.</p>","PeriodicalId":93870,"journal":{"name":"Annales de biologie clinique","volume":"82 6","pages":"651-660"},"PeriodicalIF":0.0,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143082548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anaplastic large cell T-cell lymphoma: insights from cytological and immunological profiles across ten diverse cases. 间变性大细胞t细胞淋巴瘤:从细胞学和免疫学概况的见解跨越十个不同的情况。
Pub Date : 2025-02-04 DOI: 10.1684/abc.2024.1928
Radu Chiriac, Marie Donzel, Lucile Baseggio

While the latest WHO classification of hematological neoplasms helps refine the diagnostic criteria for anaplastic large cell lymphomas (ALCL), their diagnosis can still be challenging. This retrospective series of 10 ALCL cases illustrates the cytological appearance and immunological profile obtained through flow cytometry (FCM) from various sample types, including lymph node biopsies (LN), peripheral blood (PB), cerebrospinal fluid (CSF), and pleural fluid (PF). ALCL exhibits a polymorphic cytological appearance, ranging from "doughnut" cells to Hodgkin-like cells, very large cells, and small cells, with this polymorphism being particularly pronounced in ALK (-) forms. The detection of cytotoxic CD4+ T-cells by FCM aids in confirming the diagnosis, especially in small cell forms, which typically correspond to circulating phases. Cytological orientation, particularly for LNB, helps optimize the FCM panel to be used and ensures that ALCL, which frequently shows a loss of pan-T markers, is not overlooked. In conclusion, while the final diagnosis is histological, cytological analysis combined with FCM provides an initial diagnostic orientation for ALCL and guides complementary genetic analyses.

虽然世卫组织最新的血液肿瘤分类有助于完善间变性大细胞淋巴瘤(ALCL)的诊断标准,但其诊断仍然具有挑战性。本文回顾性分析了10例ALCL病例,通过流式细胞术(FCM)从不同类型的样本中获得细胞学外观和免疫学特征,包括淋巴结活检(LN)、外周血(PB)、脑脊液(CSF)和胸膜液(PF)。ALCL表现出多形性细胞学外观,从“甜甜圈”细胞到霍奇金样细胞,非常大的细胞和小的细胞,这种多态性在ALK(-)形式中尤为明显。流式细胞术检测细胞毒性CD4+ t细胞有助于确认诊断,特别是小细胞形式,其通常对应于循环期。细胞学定位,特别是LNB,有助于优化使用的FCM面板,并确保ALCL(经常显示pan-T标记物的丢失)不会被忽视。总之,虽然最终诊断是组织学,但细胞学分析结合FCM为ALCL提供了初步诊断方向,并指导补充遗传分析。
{"title":"Anaplastic large cell T-cell lymphoma: insights from cytological and immunological profiles across ten diverse cases.","authors":"Radu Chiriac, Marie Donzel, Lucile Baseggio","doi":"10.1684/abc.2024.1928","DOIUrl":"10.1684/abc.2024.1928","url":null,"abstract":"<p><p>While the latest WHO classification of hematological neoplasms helps refine the diagnostic criteria for anaplastic large cell lymphomas (ALCL), their diagnosis can still be challenging. This retrospective series of 10 ALCL cases illustrates the cytological appearance and immunological profile obtained through flow cytometry (FCM) from various sample types, including lymph node biopsies (LN), peripheral blood (PB), cerebrospinal fluid (CSF), and pleural fluid (PF). ALCL exhibits a polymorphic cytological appearance, ranging from \"doughnut\" cells to Hodgkin-like cells, very large cells, and small cells, with this polymorphism being particularly pronounced in ALK (-) forms. The detection of cytotoxic CD4+ T-cells by FCM aids in confirming the diagnosis, especially in small cell forms, which typically correspond to circulating phases. Cytological orientation, particularly for LNB, helps optimize the FCM panel to be used and ensures that ALCL, which frequently shows a loss of pan-T markers, is not overlooked. In conclusion, while the final diagnosis is histological, cytological analysis combined with FCM provides an initial diagnostic orientation for ALCL and guides complementary genetic analyses.</p>","PeriodicalId":93870,"journal":{"name":"Annales de biologie clinique","volume":"82 6","pages":"630-639"},"PeriodicalIF":0.0,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142923981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Evaluation and contribution of molecular biology in the diagnosis of bacterial vaginosis]. 【分子生物学在细菌性阴道病诊断中的评价与贡献】。
Pub Date : 2025-02-04 DOI: 10.1684/abc.2024.1930
Mouhsine Lamtiri Laarif, Philippe Lefevre, Aurélie François, Vincent Lejeune, Jacques Freymann, Vincent Hennaux

Bacterial vaginosis, one of the most common pathologies in adult women, is defined as a chronic polymicrobial condition resulting from dysbiosis of the vaginal microbiota. Despite 70 % of patients being asymptomatic, diagnosis of this condition relies on clinico-microbiological tools. Despite being considered a gold standard technique, the Nugent score, established during microscopic examination of vaginal smears, has shown a lack of standardization and reproducibility. The discovery of new bacteria not included in the microscopic Nugent score, such as BVAB1,2,3, Atopobium sp., and Megaspheara sp., undetectable by conventional techniques, has highlighted a lack of specificity and sensitivity of the score currently provided to clinicians. This has spurred the development of new PCR kits to perform Nugent scores via molecular biology and address the shortcomings of microscopic techniques. This study has shed light on the contribution of molecular biology to the diagnosis of bacterial vaginosis, as well as the performance and limitations of the Allplex™ Bacterial Vaginosis kit marketed by Seegen® compared to microscopic examination.

细菌性阴道病是成年女性最常见的疾病之一,被定义为一种由阴道微生物群失调引起的慢性多微生物疾病。尽管70%的患者无症状,但这种疾病的诊断依赖于临床微生物学工具。尽管被认为是金标准技术,但在阴道涂片显微镜检查中建立的纽金特评分显示缺乏标准化和可重复性。显微纽金特评分中未包括的新细菌的发现,如BVAB1、2,3、Atopobium sp.和Megaspheara sp.,这些传统技术无法检测到,突出了目前提供给临床医生的评分缺乏特异性和敏感性。这刺激了新的PCR试剂盒的发展,以执行纽金特分数通过分子生物学和解决微观技术的缺点。这项研究揭示了分子生物学对细菌性阴道病诊断的贡献,以及与显微镜检查相比,Seegen®销售的Allplex™细菌性阴道病试剂盒的性能和局限性。
{"title":"[Evaluation and contribution of molecular biology in the diagnosis of bacterial vaginosis].","authors":"Mouhsine Lamtiri Laarif, Philippe Lefevre, Aurélie François, Vincent Lejeune, Jacques Freymann, Vincent Hennaux","doi":"10.1684/abc.2024.1930","DOIUrl":"10.1684/abc.2024.1930","url":null,"abstract":"<p><p>Bacterial vaginosis, one of the most common pathologies in adult women, is defined as a chronic polymicrobial condition resulting from dysbiosis of the vaginal microbiota. Despite 70 % of patients being asymptomatic, diagnosis of this condition relies on clinico-microbiological tools. Despite being considered a gold standard technique, the Nugent score, established during microscopic examination of vaginal smears, has shown a lack of standardization and reproducibility. The discovery of new bacteria not included in the microscopic Nugent score, such as BVAB1,2,3, Atopobium sp., and Megaspheara sp., undetectable by conventional techniques, has highlighted a lack of specificity and sensitivity of the score currently provided to clinicians. This has spurred the development of new PCR kits to perform Nugent scores via molecular biology and address the shortcomings of microscopic techniques. This study has shed light on the contribution of molecular biology to the diagnosis of bacterial vaginosis, as well as the performance and limitations of the Allplex™ Bacterial Vaginosis kit marketed by Seegen® compared to microscopic examination.</p>","PeriodicalId":93870,"journal":{"name":"Annales de biologie clinique","volume":"82 6","pages":"618-629"},"PeriodicalIF":0.0,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143082544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Occupational asthma in a laboratory technician]. [实验室技术人员的职业性哮喘]。
Pub Date : 2025-02-04 DOI: 10.1684/abc.2024.1935
Richard Pougnet, David Lucas, Brice Loddé, Sanna Ouedraogo, Moriamo Eniafe-Eveillard, Laurence Pougnet

This observation reports the case of an occupational allergic asthma in a laboratory technician, caused by exposure to formaldehyde. She experienced feelings of discomfort during low exposure, below the regulatory exposure thresholds. Sent to occupational medicine, signs of an asthma attack were noted by the doctor. Respiratory function tests showed bronchial hyperactivity. The diagnosis of formaldehyde asthma was made due to the recurrence of signs during exposure and the absence of other allergies. This type of occupational asthma is rare nowly and this case is an opportunity to recall what the different occupational asthmas are and which are the most common among laboratory technicians.

本观察报告的情况下,职业性过敏性哮喘的实验室技术人员,引起的甲醛暴露。她在低暴露时感到不舒服,低于规定的暴露阈值。被送到职业医学诊所,医生注意到了哮喘发作的迹象。呼吸功能检查显示支气管亢进诊断甲醛哮喘是由于暴露期间的症状复发和没有其他过敏。这种类型的职业性哮喘现在是罕见的,本病例是一个机会,回顾不同的职业性哮喘是什么,哪些是最常见的实验室技术人员。
{"title":"[Occupational asthma in a laboratory technician].","authors":"Richard Pougnet, David Lucas, Brice Loddé, Sanna Ouedraogo, Moriamo Eniafe-Eveillard, Laurence Pougnet","doi":"10.1684/abc.2024.1935","DOIUrl":"10.1684/abc.2024.1935","url":null,"abstract":"<p><p>This observation reports the case of an occupational allergic asthma in a laboratory technician, caused by exposure to formaldehyde. She experienced feelings of discomfort during low exposure, below the regulatory exposure thresholds. Sent to occupational medicine, signs of an asthma attack were noted by the doctor. Respiratory function tests showed bronchial hyperactivity. The diagnosis of formaldehyde asthma was made due to the recurrence of signs during exposure and the absence of other allergies. This type of occupational asthma is rare nowly and this case is an opportunity to recall what the different occupational asthmas are and which are the most common among laboratory technicians.</p>","PeriodicalId":93870,"journal":{"name":"Annales de biologie clinique","volume":"82 6","pages":"640-644"},"PeriodicalIF":0.0,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142928595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Checking potassium in haemolysed samples before suppressing the result can be an early warning of severe hypokalemia. 在抑制结果前检查溶血样本中的钾,可作为严重低钾血症的早期预警。
Pub Date : 2025-02-04 DOI: 10.1684/abc.2024.1933
Valentin Lemoine, Cyril Leven, Clément Capaldo

The Working Group Preanalytical Phase of the European Federation of Clinical Chemistry and Laboratory Medicine advises suppressing haemolysis-sensitive tests when haemolysis is clinically significant, as improper specimen handling can rupture red blood cells, increasing potassium levels. Thus, a correctly repeated blood sample should show lower potassium levels than a haemolysed one. This study aimed to determine the prevalence of haemolysed samples with potassium levels below the reference range and whether this predicts hypokalemia in repeated collections. From March 2022 to March 2024, 396,640 non-haemolysed samples (H-index < 2 UA) were analyzed. Samples with an H-index ≥ 2 AU were classified as haemolysed, and potassium values were suppressed. Warnings were issued for haemolysed samples with potassium below the reference range (3.4-4.5 mmol/L), advising new sample collection. Twenty-five (0.01%) repeat samples were taken within 24 hours of a previously haemolysed sample with low potassium. Severe and moderate hypokalemia were more common in these repeats, with severe hypokalemia (≤2.5 mmol/L) found in 48% of repeat tests, compared to 0.3% in all samples. Though rare, a decrease in potassium in haemolysed samples often precedes hypokalemia diagnosis. Implementing a simple and cost-effective LIS algorithm to alert clinicians could potentially reduce diagnosis and treatment time.

欧洲临床化学和实验室医学联合会分析前阶段工作组建议,当溶血有临床意义时,应抑制溶血敏感试验,因为不适当的标本处理会使红细胞破裂,增加钾水平。因此,正确重复的血液样本应该显示钾含量低于溶血样本。本研究旨在确定钾水平低于参考范围的溶血样本的患病率,以及这是否预示着反复收集的低钾血症。从2022年3月至2024年3月,共分析了396640份非溶血样本(h指数< 2ua)。h指数≥2 AU的样品被归类为溶血,钾值被抑制。对钾低于参考范围(3.4-4.5 mmol/L)的溶血样品发出警告,建议重新采集样品。25个(0.01%)重复样品在24小时内取先前溶血低钾样品。重度和中度低钾血症在这些重复试验中更为常见,在48%的重复试验中发现重度低钾血症(≤2.5 mmol/L),而在所有样品中这一比例为0.3%。虽然罕见,但溶血样品中钾的减少通常先于低钾血症的诊断。实施一种简单且具有成本效益的LIS算法来提醒临床医生,可能会缩短诊断和治疗时间。
{"title":"Checking potassium in haemolysed samples before suppressing the result can be an early warning of severe hypokalemia.","authors":"Valentin Lemoine, Cyril Leven, Clément Capaldo","doi":"10.1684/abc.2024.1933","DOIUrl":"10.1684/abc.2024.1933","url":null,"abstract":"<p><p>The Working Group Preanalytical Phase of the European Federation of Clinical Chemistry and Laboratory Medicine advises suppressing haemolysis-sensitive tests when haemolysis is clinically significant, as improper specimen handling can rupture red blood cells, increasing potassium levels. Thus, a correctly repeated blood sample should show lower potassium levels than a haemolysed one. This study aimed to determine the prevalence of haemolysed samples with potassium levels below the reference range and whether this predicts hypokalemia in repeated collections. From March 2022 to March 2024, 396,640 non-haemolysed samples (H-index < 2 UA) were analyzed. Samples with an H-index ≥ 2 AU were classified as haemolysed, and potassium values were suppressed. Warnings were issued for haemolysed samples with potassium below the reference range (3.4-4.5 mmol/L), advising new sample collection. Twenty-five (0.01%) repeat samples were taken within 24 hours of a previously haemolysed sample with low potassium. Severe and moderate hypokalemia were more common in these repeats, with severe hypokalemia (≤2.5 mmol/L) found in 48% of repeat tests, compared to 0.3% in all samples. Though rare, a decrease in potassium in haemolysed samples often precedes hypokalemia diagnosis. Implementing a simple and cost-effective LIS algorithm to alert clinicians could potentially reduce diagnosis and treatment time.</p>","PeriodicalId":93870,"journal":{"name":"Annales de biologie clinique","volume":"82 6","pages":"665-667"},"PeriodicalIF":0.0,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142923909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Clostridioides difficile infection diagnosis]. [艰难梭菌感染诊断]。
Pub Date : 2025-02-04 DOI: 10.1684/abc.2024.1927
Jeanne Couturier, Muriel Ehmig, Imane Mostaghat, Frédéric Barbut

Clostridioides difficile is a Gram-positive, spore-forming anaerobic enteropathogen responsible for a wide spectrum of clinical diseases ranging from mild diarrhoea to pseudomembranous colitis. It is the first cause of healthcare-associated diarrhoeas, but community-associated Clostridioides difficile infections (CDI) are increasingly reported in patients without the common risk factors (age > 65 years, previous antibiotic treatment). The main C. difficile virulence factors are toxins A (TcdA) and B (TcdB), and in some cases the binary toxin. The CDI incidence has increased in Europe since the early 2000s, then decreased to reach approximately 4 cases/10,000 patients/days. C. difficile should be tested only in diarrheal stools. Children less than 3 years old are frequently colonized, therefore CDI diagnosis should be carried out only in specific cases (outbreak, Hirschsprung disease). No stand-alone method can be used for the CDI diagnosis. The European Society for Clinical Microbiology and Infectious Diseases (ESCMID) recommends a two-step algorithm with a sensitive screening test (molecular assay or glutamate dehydrogenase immunochromatographic assay). If the screening test is negative, the CDI diagnosis can be ruled out. If the screening test is positive, a second highly specific test should be used, such as toxin A/B immunochromatographic assay.

艰难梭菌是一种革兰氏阳性、孢子形成的厌氧肠病原体,可引起从轻度腹泻到假膜性结肠炎等广泛的临床疾病。它是卫生保健相关性腹泻的首要原因,但社区相关性艰难梭菌感染(CDI)越来越多地报告发生在没有常见危险因素(年龄0 ~ 65岁,既往接受过抗生素治疗)的患者中。艰难梭菌的主要毒力因子是毒素A (TcdA)和毒素B (TcdB),在某些情况下是二元毒素。自21世纪初以来,CDI发病率在欧洲有所增加,随后下降至约4例/10,000例患者/天。艰难梭菌只应在腹泻便中检测。3岁以下儿童经常有定植,因此CDI诊断应仅在特定情况下进行(爆发,巨结肠病)。没有独立的方法可以用于CDI诊断。欧洲临床微生物学和传染病学会(ESCMID)建议采用两步算法进行敏感筛选试验(分子试验或谷氨酸脱氢酶免疫层析试验)。如果筛查结果为阴性,则可排除CDI诊断。如果筛选试验呈阳性,则应采用第二种高度特异性的试验,如毒素a /B免疫层析试验。
{"title":"[Clostridioides difficile infection diagnosis].","authors":"Jeanne Couturier, Muriel Ehmig, Imane Mostaghat, Frédéric Barbut","doi":"10.1684/abc.2024.1927","DOIUrl":"10.1684/abc.2024.1927","url":null,"abstract":"<p><p>Clostridioides difficile is a Gram-positive, spore-forming anaerobic enteropathogen responsible for a wide spectrum of clinical diseases ranging from mild diarrhoea to pseudomembranous colitis. It is the first cause of healthcare-associated diarrhoeas, but community-associated Clostridioides difficile infections (CDI) are increasingly reported in patients without the common risk factors (age > 65 years, previous antibiotic treatment). The main C. difficile virulence factors are toxins A (TcdA) and B (TcdB), and in some cases the binary toxin. The CDI incidence has increased in Europe since the early 2000s, then decreased to reach approximately 4 cases/10,000 patients/days. C. difficile should be tested only in diarrheal stools. Children less than 3 years old are frequently colonized, therefore CDI diagnosis should be carried out only in specific cases (outbreak, Hirschsprung disease). No stand-alone method can be used for the CDI diagnosis. The European Society for Clinical Microbiology and Infectious Diseases (ESCMID) recommends a two-step algorithm with a sensitive screening test (molecular assay or glutamate dehydrogenase immunochromatographic assay). If the screening test is negative, the CDI diagnosis can be ruled out. If the screening test is positive, a second highly specific test should be used, such as toxin A/B immunochromatographic assay.</p>","PeriodicalId":93870,"journal":{"name":"Annales de biologie clinique","volume":"82 6","pages":"609-617"},"PeriodicalIF":0.0,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142924052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annales de biologie clinique
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1